Recent News

• 11.06.2026 - CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
• 10.25.2026 - WSAUA 2026 – Expanded Access Program Poster
• 10.25.2026 - WSAUA 2026 – CORE-008 Cohort CX Poster
• 10.25.2026 - WSAUA 2026 – CORE-008 Cohort A Poster
• 10.25.2026 - WSAUA 2026 – BOND-003 Cohort P Poster
• 10.25.2026 - WSAUA 2026 – BOND-003 Cohort C Poster
• 10.24.2026 - NEAUA 2026 – CORE-008 Cohort A and PK/PD Podium
• 10.24.2026 - NEAUA 2026 – CORE-008 Cohort CX Topline Podium
• 10.24.2026 - SUNA 2026 – Cretostimogene Optimized Administration Podium
• 10.23.2026 - NEAUA 2026 – BOND-003 Cohort C Durable 24-Mo Outcomes Podium

Recent Filings

• 11.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2026 - 8-K Current report
• 11.06.2026 - EX-99.1 EX-99.1
• 10.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 10.19.2026 - 3 Initial statement of beneficial ownership of securities
• 10.15.2026 - 144 Report of proposed sale of securities
• 09.21.2026 - 144 Report of proposed sale of securities
• 09.17.2026 - 144 Report of proposed sale of securities
• 09.17.2026 - 4 Statement of changes in beneficial ownership of securities